Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study

Eero Poukka; Caren van Roekel; Topi Turunen; Ulrike Baum; Rolf Kramer; Elizabeth Begier; Lance D. Presser; Anne C. Teirlinck; Terho Heikkinen; Mirjam Knol; Hanna Nohynek; Louis Bont

doi:10.1093/infdis/jiad484

Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study

Eero Poukka^*, Caren van Roekel, Topi Turunen, Ulrike Baum, Rolf Kramer, Elizabeth Begier, Lance D. Presser, Anne C. Teirlinck, Terho Heikkinen, Mirjam Knol, Hanna Nohynek, Louis Bont,

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.

Original language	English
Pages (from-to)	S84-S91
Journal	Journal of Infectious Diseases
Volume	229
DOIs	https://doi.org/10.1093/infdis/jiad484
Publication status	Published - 15 Mar 2024

Keywords

maternal immunization
monoclonal antibody
respiratory syncytial virus
RSV
vaccine

Access to Document

10.1093/infdis/jiad484

Cite this

Poukka, E., Roekel, C. V., Turunen, T., Baum, U., Kramer, R., Begier, E., Presser, L. D., Teirlinck, A. C., Heikkinen, T., Knol, M., Nohynek, H., Bont, L. (2024). Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study. Journal of Infectious Diseases, 229, S84-S91. https://doi.org/10.1093/infdis/jiad484

@article{9874fd439f5c4a36bc5a90b9f5b9a2ee,

title = "Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study",

abstract = "Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.",

keywords = "maternal immunization, monoclonal antibody, respiratory syncytial virus, RSV, vaccine",

author = "Eero Poukka and Roekel, {Caren van} and Topi Turunen and Ulrike Baum and Rolf Kramer and Elizabeth Begier and Presser, {Lance D.} and Teirlinck, {Anne C.} and Terho Heikkinen and Mirjam Knol and Hanna Nohynek and Harish Nair and Harry Campbell and Louis Bont and Leor Perl and Adam Meijer and Shiri Soudry and David Gideonse and Anoek Backx and Melker, {Hester de} and Presser, {Lance D.} and Rachel Cohen and Xin Wang and Annika Saukkoriipi and John Paget and Summeren, {Jojanneke van} and Michel D{\"u}ckers and Daniel Sperling and Audenis, {Berta Gum{\'i}} and Maica Llavero and Leyla Kragten and Lies Kriek and Krist{\'y}na Faksov{\'a} and Michele Giardini and Emborg, {Hanne Dorthe} and Francesca Rocchi and Quiles, {Cintia Mu{\~n}oz} and Javier Diez-Domingo and Charlotte Vernhes and Clarisse Demont and Aurelie Robin and David Neveu and Lydie Marcelon and Mathieu Bangert and Jamal Daghash and Oliver Martyn and Corinne Bardone and Vanessa Remy and Sandra Chaves",

year = "2024",

month = mar,

day = "15",

doi = "10.1093/infdis/jiad484",

language = "English",

volume = "229",

pages = "S84--S91",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

}

Poukka, E, Roekel, CV, Turunen, T, Baum, U, Kramer, R, Begier, E, Presser, LD, Teirlinck, AC, Heikkinen, T, Knol, M, Nohynek, H, Bont, L 2024, 'Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study', Journal of Infectious Diseases, vol. 229, pp. S84-S91. https://doi.org/10.1093/infdis/jiad484

TY - JOUR

T1 - Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus

T2 - Generic Protocol for Register-Based Cohort Study

AU - Poukka, Eero

AU - Roekel, Caren van

AU - Turunen, Topi

AU - Baum, Ulrike

AU - Kramer, Rolf

AU - Begier, Elizabeth

AU - Presser, Lance D.

AU - Teirlinck, Anne C.

AU - Heikkinen, Terho

AU - Knol, Mirjam

AU - Nohynek, Hanna

AU - Nair, Harish

AU - Campbell, Harry

AU - Bont, Louis

AU - Perl, Leor

AU - Meijer, Adam

AU - Soudry, Shiri

AU - Gideonse, David

AU - Backx, Anoek

AU - Melker, Hester de

AU - Presser, Lance D.

AU - Cohen, Rachel

AU - Wang, Xin

AU - Saukkoriipi, Annika

AU - Paget, John

AU - Summeren, Jojanneke van

AU - Dückers, Michel

AU - Sperling, Daniel

AU - Audenis, Berta Gumí

AU - Llavero, Maica

AU - Kragten, Leyla

AU - Kriek, Lies

AU - Faksová, Kristýna

AU - Giardini, Michele

AU - Emborg, Hanne Dorthe

AU - Rocchi, Francesca

AU - Quiles, Cintia Muñoz

AU - Diez-Domingo, Javier

AU - Vernhes, Charlotte

AU - Demont, Clarisse

AU - Robin, Aurelie

AU - Neveu, David

AU - Marcelon, Lydie

AU - Bangert, Mathieu

AU - Daghash, Jamal

AU - Martyn, Oliver

AU - Bardone, Corinne

AU - Remy, Vanessa

AU - Chaves, Sandra

PY - 2024/3/15

Y1 - 2024/3/15

N2 - Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.

AB - Several immunization products are currently being developed against respiratory syncytial virus (RSV) for children, pregnant females, and older adults, and some products have already received authorization. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct postmarketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunization product effectiveness against RSV-specific and nonspecific outcomes. To conduct a study on the basis of this generic protocol, the researchers can use any relevant databases or healthcare registers that are available at the study site.

KW - maternal immunization

KW - monoclonal antibody

KW - respiratory syncytial virus

KW - RSV

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=85186564817&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiad484

DO - 10.1093/infdis/jiad484

M3 - Article

C2 - 37930815

AN - SCOPUS:85186564817

SN - 0022-1899

VL - 229

SP - S84-S91

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

ER -

Effectiveness of Vaccines and Monoclonal Antibodies Against Respiratory Syncytial Virus: Generic Protocol for Register-Based Cohort Study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this